INVO Bioscience, Inc. (INVO)

INVO Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-8.03	-10.89	-6.65	-8.35	-2.17
Depreciation & Amortization	0.2	0.08	0.17	0.03	0.03
Share-Based Compensation	1.29	2.22	1.9	1.61	0.09
Other Operating Activities	1.79	1.99	-1.45	1.93	3.43
Operating Cash Flow	-4.76	-6.6	-6.03	-4.78	1.37
Capital Expenditures	-0.44	-0.01	-0.45	-0.09	-0.06
Acquisitions	-2.05	-0.07	-1.7	-0.1	0
Other Investing Activities	-	-	-	-0	-0.05
Investing Cash Flow	-2.49	-0.08	-2.15	-0.19	-0.11
Share Issuance / Repurchase	5.7	0.29	3.9	11.48	0
Debt Issued / Paid	1.66	0.8	-0.25	2.35	-0.23
Other Financing Activities	0.02	-	0.12	-	-
Financing Cash Flow	7.39	1.09	3.77	13.82	-0.23
Net Cash Flow	0.14	-5.59	-4.41	8.86	1.03
Free Cash Flow	-5.2	-6.62	-6.48	-4.86	1.31
Free Cash Flow Margin	-172.15%	-804.68%	-155.87%	-468.92%	88.21%
Free Cash Flow Per Share	-3.32	-10.91	-12.20	-17.72	5.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).